“…Low-calorie sweeteners) postprandial hyperglycemia | intervention trials | studies in English language | ND | MEDLINE, Web of Science | Shankar, 2013 [ 279 ] | ND | NNS consumption | obesity/weight gain; diabetes; cardiometabolic indicators | ND | ND | 2012 | MEDLINE |
Spencer, 2016 [ 280 ] | humans and animals | aspartame, saccharin or sucralose consumption | fermentation, absorption, gastrointestinal symptoms | ND | full articles in English language | June 2015 | MEDLINE, EMBASE |
Timpe Behnen, 2013 [ 281 ] | diabetes patients | acesulfame, aspartame,luo han guo, monk fruit, neotame, rebiana, saccharin, stevia, and sucralose | diabetic control, including, but not limited to, blood glucose levels, postprandial blood glucose, HbA1c | clinical studies | studies in English language | May 2012 | MEDLINE, Scopus |
Wiebe, 2011 [ 23 ] | ND | a sweetener (e.g. non-caloric sweetener) | weight change, energy intake, lipids, HbA1C, insulin resistance | parallel or crossover RCT | follow-up at least 1 week in duration; at least 10 participants per group, no trials with placebo control | January 2011 | MEDLINE, EMBASE, Cochrane Library CENTRAL, CAB Global |
Oliver, 2015 [ 85 ] | ND | aspartame, ace-K, cyclamic acid and its salts, steviol glycosides, neohesperidin DC, neotame, saccharine and its salts, sucralose,aspartame-acesulfame salt, thaumatin | benefits and risks related to intense sweeteners | meta-analysis, RCTs, quasi experimental, cohort, case-control, cross-sectional studies | none | ND | MEDLINE, Cochrane Database of Systematic Reviews, Psychinfo |
Onakpoya, 2015 [ 21 ] | adult volunteers (>18 y) | steviol glycoside | cardiovascular risk factors (blood pressure, blood sugar, cholesterol) | double-blind RCTs | No age, language or time restrictions. Studies in which steviol glycosides were combined with other dietary supplements were excluded | May 2014 | MEDLINE, EMBASE, Amed, Cinahl, Th... |
…”